OS

Oscar Slotboom

Managing Partner BioGeneration Ventures

Naarden, North Holland

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $1,000,000.00

  • Target Investment:

    $500,000.00

Skills

Infectious Diseases
Due Diligence
Vaccines
Business Development
Management Consulting
Project Management
Change Management
Biotechnology
Cross-functional Team Leadership
R&D
Pharmaceutical Industry
Lifesciences
Biopharmaceuticals
Business Planning
Strategy
Business Strategy
Management
Technology Transfer
Start-ups
Commercialization

Education

Investments

CatalYm

Series C

Total Funding: $200M

NorthSea Therapeutics

Series A

Total Funding: $150M

Dunad Therapeutics

Series A

Total Funding: $24M

VarmX

Seed

Total Funding: $83M

Mellon Medical

Series B

Total Funding: $7M

SurgVision

Series Unknown

Total Funding:

Work Experience

BioGeneration Ventures

2016

  • Managing Partner

    2016

Avantium

2014 - 2016

  • Chief Commercial Officer

    2014 - 2016

Crucell China / Xian Janssen (part of Johnson&Johnson)

2012 - 2014

  • BU Head, Vaccines and Infectious Diseases

    2012 - 2014

Crucell

2006 - 2012

  • Business Manager Paediatric

    2008 - 2012

  • Director Business Development

    2006 - 2008

McKinsey & Company

1999 - 2006

  • Engagement Manager

    2004 - 2006

  • Consultant

    1999 - 2006

  • Associate

    2002 - 2004

  • Fellow

    1999 - 2001